74 related articles for article (PubMed ID: 31409916)
21. [The aldosterone to Renin ratio in secondary hypertension].
Seiler L; Reincke M
Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
[TBL] [Abstract][Full Text] [Related]
22. Functional tests for primary aldosteronism: value of captopril suppression.
Racine MC; Douville P; Lebel M
Curr Hypertens Rep; 2002 Jun; 4(3):245-9. PubMed ID: 12003708
[TBL] [Abstract][Full Text] [Related]
23. Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism.
Yamashita K; Morimoto S; Seki Y; Watanabe D; Ichihara A
Hypertens Res; 2019 Dec; 42(12):1951-1960. PubMed ID: 31409916
[TBL] [Abstract][Full Text] [Related]
24. Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level.
Bokuda K; Morimoto S; Seki Y; Yatabe M; Watanabe D; Yatabe J; Ando T; Shimizu S; Itoh H; Ichihara A
Hypertens Res; 2018 Jun; 41(6):435-443. PubMed ID: 29618841
[TBL] [Abstract][Full Text] [Related]
25. Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.
Nguyen G; Blanchard A; Curis E; Bergerot D; Chambon Y; Hirose T; Caumont-Prim A; Tabard SB; Baron S; Frank M; Totsune K; Azizi M
Hypertension; 2014 Feb; 63(2):297-302. PubMed ID: 24218434
[TBL] [Abstract][Full Text] [Related]
26. Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.
Grotevendt A; Wallaschofski H; Reincke M; Adolf C; Quinkler M; Nauck M; Hoffmann W; Rettig R; Hannemann A
Endocrine; 2017 Aug; 57(2):298-307. PubMed ID: 28638984
[TBL] [Abstract][Full Text] [Related]
27. Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
Recarti C; Seccia TM; Caroccia B; Gonzales-Campos A; Ceolotto G; Lenzini L; Petrelli L; Belloni AS; Rainey WE; Nussberger J; Rossi GP
J Hypertens; 2015 May; 33(5):1014-22. PubMed ID: 25668351
[TBL] [Abstract][Full Text] [Related]
28. Continuum of Renin-Independent Aldosteronism in Normotension.
Baudrand R; Guarda FJ; Fardella C; Hundemer G; Brown J; Williams G; Vaidya A
Hypertension; 2017 May; 69(5):950-956. PubMed ID: 28289182
[TBL] [Abstract][Full Text] [Related]
29. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
[TBL] [Abstract][Full Text] [Related]
30. Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.
Kishimoto S; Matsumoto T; Oki K; Maruhashi T; Kajikawa M; Matsui S; Hashimoto H; Kihara Y; Yusoff FM; Higashi Y
Hypertens Res; 2018 Nov; 41(11):932-938. PubMed ID: 30206323
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.
Ohno Y; Sone M; Inagaki N; Yamasaki T; Ogawa O; Takeda Y; Kurihara I; Itoh H; Umakoshi H; Tsuiki M; Ichijo T; Katabami T; Tanaka Y; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Okamura S; Miyauchi S; Fukuoka T; Izawa S; Yoneda T; Hashimoto S; Yanase T; Suzuki T; Kawamura T; Tabara Y; Matsuda F; Naruse M; ;
Hypertension; 2018 Mar; 71(3):530-537. PubMed ID: 29358460
[TBL] [Abstract][Full Text] [Related]
32. New approach to arterial stiffness: BP-independent local carotid stiffness.
Shiina K; Tomiyama H
Hypertens Res; 2017 Nov; 40(11):910-911. PubMed ID: 28814786
[No Abstract] [Full Text] [Related]
33. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.
Monticone S; Burrello J; Tizzani D; Bertello C; Viola A; Buffolo F; Gabetti L; Mengozzi G; Williams TA; Rabbia F; Veglio F; Mulatero P
J Am Coll Cardiol; 2017 Apr; 69(14):1811-1820. PubMed ID: 28385310
[TBL] [Abstract][Full Text] [Related]
34. Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis Patients.
Amari Y; Morimoto S; Nakajima F; Ando T; Ichihara A
PLoS One; 2016; 11(7):e0158068. PubMed ID: 27367528
[TBL] [Abstract][Full Text] [Related]
35. Soluble (pro)renin receptor via β-catenin enhances urine concentration capability as a target of liver X receptor.
Lu X; Wang F; Xu C; Soodvilai S; Peng K; Su J; Zhao L; Yang KT; Feng Y; Zhou SF; Gustafsson JÅ; Yang T
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1898-906. PubMed ID: 26984496
[TBL] [Abstract][Full Text] [Related]
36. Serum soluble (pro)renin receptor levels in patients with essential hypertension.
Morimoto S; Ando T; Niiyama M; Seki Y; Yoshida N; Watanabe D; Kawakami-Mori F; Kobori H; Nishiyama A; Ichihara A
Hypertens Res; 2014 Jul; 37(7):642-8. PubMed ID: 24646643
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
